John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$187M |
| 2 |
TJX Companies
TJX
|
+$177M |
| 3 |
Dominion Energy
D
|
+$150M |
| 4 |
Citigroup
C
|
+$150M |
| 5 |
Domino's
DPZ
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$189M |
| 2 |
Lowe's Companies
LOW
|
+$177M |
| 3 |
Home Depot
HD
|
+$168M |
| 4 |
Becton Dickinson
BDX
|
+$149M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.52% |
| 2 | Technology | 13.18% |
| 3 | Industrials | 10.7% |
| 4 | Healthcare | 9.05% |
| 5 | Consumer Staples | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNR
1051
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $4.24M | 0.01% |
281,911
-8,686
| -3% | -$136K |
|
1052
CALL
Everest Group
EG
$14.4B
| $4.24M | 0.01% |
16,500
+9,200
| +126% | +$2.21M |
|
1053
Enovis
ENOV
$1.45B
| $4.22M | 0.01% |
76,892
+19,985
| +35% | +$1.23M |
|
|
FNGN
1054
DELISTED
Financial Engines, Inc.
FNGN
| $4.22M | 0.01% |
120,501
+78,601
| +188% | +$2.47M |
|
1055
CALL
PepsiCo
PEP
$197B
| $4.21M | 0.01% |
+38,600
| New | +$4.39M |
|
|
NTRI
1056
DELISTED
NutriSystem, Inc.
NTRI
| $4.2M | 0.01% |
+155,943
| New | +$6.21M |
|
1057
Ezcorp Inc
EZPW
$2.15B
| $4.19M | 0.01% |
317,433
-85,682
| -21% | -$1.09M |
|
1058
Prospect Capital
PSEC
$1.16B
| $4.19M | 0.01% |
639,383
-1,019,336
| -61% | -$6.81M |
|
1059
CALL
C.H. Robinson
CHRW
$16.7B
| $4.17M | 0.01% |
+44,500
| New | +$4.1M |
|
1060
Marcus & Millichap
MMI
$1.23B
| $4.17M | 0.01% |
115,510
+48,110
| +71% | +$1.57M |
|
1061
Sarepta Therapeutics
SRPT
$1.92B
| $4.16M | 0.01% |
+56,203
| New | +$3.75M |
|
1062
LivaNova
LIVN
$4.31B
| $4.16M | 0.01% |
46,946
-92,666
| -66% | -$7.89M |
|
1063
Constellium
CSTM
$3.61B
| $4.15M | 0.01% |
382,669
-701,860
| -65% | -$8.56M |
|
1064
CALL
Steel Dynamics
STLD
$32.9B
| $4.14M | 0.01% |
93,600
+83,700
| +845% | +$3.85M |
|
1065
CALL
Bristol-Myers Squibb
BMY
$137B
| $4.14M | 0.01% |
+65,400
| New | +$4.21M |
|
1066
PUT
Netflix
NFLX
$333B
| $4.13M | 0.01% |
140,000
-1,380,000
| -91% | -$37.6M |
|
1067
Onto Innovation
ONTO
$17.3B
| $4.13M | 0.01% |
153,535
-9,574
| -6% | -$256K |
|
1068
PUT
Jack in the Box
JACK
$342M
| $4.12M | 0.01% |
+48,300
| New | +$4.32M |
|
1069
CALL
iShares MSCI Brazil ETF
EWZ
$8.07B
| $4.11M | 0.01% |
91,600
+65,400
| +250% | +$2.92M |
|
1070
Reliance Steel & Aluminium
RS
$19.5B
| $4.11M | 0.01% |
+47,873
| New | +$4.28M |
|
|
MNK
1071
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.09M | 0.01% |
282,481
-1,084,577
| -79% | -$19.6M |
|
1072
CALL
Boston Properties
BXP
$11.2B
| $4.08M | 0.01% |
+33,100
| New | +$4.02M |
|
1073
CALL
Core Laboratories
CLB
$553M
| $4.07M | 0.01% |
37,600
+16,400
| +77% | +$1.81M |
|
1074
HubSpot
HUBS
$12.2B
| $4.06M | 0.01% |
37,529
+19,525
| +108% | +$2.03M |
|
1075
Hexcel
HXL
$7B
| $4.06M | 0.01% |
62,893
-97,575
| -61% | -$6.43M |
|
Similar funds
John Overdeck's Q1 2018 Portfolio in Review
As of Q1 2018, John Overdeck held 3,845 positions worth $30B, down 2.2% from $30.7B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
John Overdeck's Q1 2018 filing shows 807 new, 1,057 increased, 1,203 reduced and 766 closed positions. Its largest new stake was TJX Companies: 4,481,478 shares worth $183M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $189M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
- John Overdeck's largest Q1 2018 buy was TJX Companies: 4,481,478 shares worth $183M.
- John Overdeck added most to Target in Q1 2018, an estimated $187M increase.
- John Overdeck's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $189M.
- John Overdeck fully exited Walgreens Boots Alliance in Q1 2018, selling an estimated $129M.
- John Overdeck's ten largest holdings make up 5.7% of its $30B portfolio in Q1 2018.
- John Overdeck opened 807 new positions and closed 766 in Q1 2018.
- John Overdeck's portfolio value fell 2.2% quarter-over-quarter to $30B.
Based on Two Sigma Investments's 13F filing for Q1 2018, filed 15 May 2018.